Homozygous Familial Hypercholesterolemia
📧 Sign up to get email alerts when something new happens for Homozygous Familial Hypercholesterolemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: The Rogosin Institute Homozygous Familial Hypercholesterolemia Repository
The Rogosin Institute is recruiting for a repository study focused on Homozygous Familial Hypercholesterolemia.
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: A Dose-exploration Study of EDP167 in HoFH [Phase 2]
A Phase 2 dose-exploration trial of EDP167 for homozygous familial hypercholesterolemia is currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: A Phase 3 Study of Zodasiran in Adolescent and Adult Subjects With Homozygous Familial Hypercholesterolemia (YOSEMITE) [Phase 3]
A Phase 3 clinical trial (YOSEMITE) evaluating Zodasiran in adolescent and adult subjects with Homozygous Familial Hypercholesterolemia is c…
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: The ORIGIN-FH Study [NA]
The ORIGIN-FH clinical trial is currently recruiting to study familial hypercholesterolemia, including heterozygous and homozygous forms.
-
CLINICAL_TRIALS research · 2026-03-03Clinical Trial Update: Assessing the Impact of Intensification of Lipid Lowering Therapy With Guidelines-based Evinacumab Administration on Coronary Plaque Volumes Measured by Coronary Computed Tomography Angiography (CCTA) in Patients With Homozygous Familial Hypercholesterolemia (HoFH)
A clinical trial update evaluating intensified lipid-lowering therapy with guidelines-based evinacumab for Homozygous Familial Hypercholeste…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-02-20Clinical Trial Update: Study to Evaluate Safety, Tolerability and Efficacy of Inclisiran in Children With Homozygous Familial Hypercholesterolemia [Phase 3]
A Phase 3 clinical trial is evaluating the safety, tolerability, and efficacy of Inclisiran in children with homozygous familial hypercholes…
-
CLINICAL_TRIALS research · 2026-02-20Clinical Trial Update: Evaluation of the Effect of Lomitapide Treatment on Major Adverse Cardiovascular Events (MACE) in Patients With Homozygous Familial Hypercholesterolemia
This clinical trial update examines the effect of lomitapide on major adverse cardiovascular events in patients with homozygous familial hyp…
-
CLINICAL_TRIALS research · 2025-12-18Clinical Trial Update: HoFH, the International Clinical Collaborators Registry
Clinical trial update announcing the International Collaborators Registry for Homozygous Familial Hypercholesterolemia, currently recruiting…
-
CLINICAL_TRIALS research · 2025-10-10Clinical Trial Update: Study of ARO-ANG3 in Participants With Homozygous Familial Hypercholesterolemia (HOFH) [Phase 2]
A Phase 2 clinical trial update for ARO-ANG3 in participants with Homozygous Familial Hypercholesterolemia, currently active but not recruit…
-
CLINICAL_TRIALS research · 2024-12-09Clinical Trial Update: NGGT006 Gene Therapy for Homozygous Familial Hypercholesterolemia [EARLY_Phase 1]
Early-phase clinical trial update for NGGT006 gene therapy targeting Homozygous Familial Hypercholesterolemia; currently recruiting.